17th report of Session 2005-06 : Government of Wales Bill; Childcare Bill; Safeguarding Vulnerable Groups Bill (HL); Violent Crime Reduction Bill - Government response; Proposal for the Regulatory Reform (Registered Designs) Order 2006
23rd report of Session 2005-06 : Armed Forces Bill; Education and Inspections Bill; International Development (Reporting and Transparency) Bill; Government of Wales Bill - Government response; Northern Ireland (Miscellaneous Provisions) Bill - Government
This report looks at the proposal from the European Commission to replace the existing Directive on consumer credit and replace it with on that aims to offer a higher level of consumer protection and promote an internal market in cross-border credit. It concentrates on three questions: will the proposed harmonisation achieve its objective; will it provide a high level of consumer; will it reduce the amount of protection offered by current UK legislation. It identifies a number of concerns, which it hopes will be addressed by further changes to the text of the draft Directive. And recommends that the issue should be debated I the House
The European Commission want to set up a European Institute for Gender Equality to collect and analyse data, carry out research and promote exchanges of information and good practice about gender issues in the EU. The European Union Committee expresses the view that a separate body of this kind is not needed, and that more consideration should be given to the case for incorporating gender equality work in the proposed European Fundamental Rights Agency. The Committee also states that the establishment of such a body requires a good management structure along with adequate funding. The Committee further states that the Government should take a clear and consistent line on the correct legal base for this and similar proposals.
Over 50 per cent of all medicines given to children (and about 90 per cent of those given to the newly-born) have never been tested or authorised for use on them. The Committee's report examines the European Commission's proposal to introduce a Regulation (the Clinical Trials Directive) on medicinal products for paediatric use which aims to stimulate the development of medicines for children and lay down rules for testing and approval. Issues discussed include: the need for better regulation of paediatric medicines; the ethical considerations involved in clinical trials on children, including the issue of consent; mechanisms for implementing the Regulation; access to the database of information on clinical trials; the rewards and incentives proposed to stimulate the research and development of medicines; and the legal basis for the regulation under the EC Treaty. The Committee's report recognises the urgent need for effective action at the European level to authorise medicines for paediatric use and gives broad support to the proposed Directive. However, a number of key issues are highlighted, including: the need for improved labelling of medicines; that the guidelines underpinning the Directive should take account of ethical considerations involved to ensure the rights and capacity of children to give informed consent to trials; and concerns are raised about the adequacy of proposed incentive mechanisms.
This report by the European Union Committee examines the progress of the European Union in initiating a strategy for jobs and growth across the Community as a whole. The background to this report stems from the Spring European Council meeting in 2000, in Lisbon, and the launch of an economic reform agenda. The Committee observes that since the "Lisbon Agenda", little progress has been made and the performance of many of the larger European economies has been poor. The Committee has noted that certain worrying signs of protectionist behaviour have developed, especially regarding barriers of cross border mergers. The EU has recognized this weak performance and the Agenda was relaunched in 2005, with a greater focus on the key economic priorities of more growth and jobs. Also, all Member States are now required to produce an annual National Action Plan highlighting the policies being pursued to improve economic growth and increase employment. The Committee sets out a number of recommendations to further push forward the priorities of growth and jobs, including: that the Commission should seek to complete the progress towards an internal market; that Member States should influence one another in the development of good practice through statistical comparison of their economic progress, and agree on quantifiable targets; that the format of the National Action Plans should include not only the successes, but where countries are underperforming; that the Agenda be given a higher public profile.
This report informs the House about the Commission's proposals fro the 2007 General Budget of the European Communities. The report is in four sections. The first explains how the budget is decided and the Committee's role. The second looks at the seven year financial programme, 2007-13. The third section summarises the significant proposed changes to funding under each of the budget headings. The final section is a summary of conclus
This report finds that the funding of the EU is complex and lacks transparency and that there is a need for a simpler system that would reduce the administrative burden. It concludes that a Gross National Income based revenue source is the best way of providing the bulk of the budget's funding. Apart from other considerations, the Committee has seen no evidence that any other new form of taxation would provide the same level of clarity and certainty.
The Government is expected to respond to all reports from the Committee, within two months of publication The Committee then makes them available to the House and publishes them as required. This report makes 35 such responses available.